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Background: Late assembly (L)-domains are protein interaction motifs, whose dysfunction causes characteristic
budding defects in enveloped viruses. Three different amino acid motifs, namely PT/SAP, PPXY and YPXnL have
been shown to play a major role in the release of exogenous retroviruses. Although the L-domains of exogenous
retroviruses have been studied comprehensively, little is known about these motifs in endogenous human retrovi-
ruses.
Results: Using a molecular clone of the human endogenous retrovirus K113 that had been engineered to reverse
the presumed non-synonymous postinsertional mutations in the major genes, we identified three functional
L-domains of the virus, all located in the Gag p15 protein. A consensus PTAP tetrapeptide serves as the core of a
main L-domain for the virus and its inactivation reduces virus release in HEK 293T cells by over 80%. Electron
microscopy of cells expressing the PTAP mutant revealed predominantly late budding structures and budding
chains at the plasma membrane. The fact that this motif determines subcellular colocalization with Tsg101, an
ESCRT-I complex protein known to bind to the core tetrapeptide, supports its role as an L-domain. Moreover, two
YPXnL motifs providing additional L-domain function were identified in the p15 protein. One is adjacent to the
PTAP sequence and the other is in the p15 N-terminus. Mutations in either motif diminishes virus release and
induces an L-domain phenotype while inactivation of all three L-domains results in a complete loss of particle
release in HEK 293T cells. The flexibility of the virus in the use of L-domains for gaining access to the ESCRT
machinery is demonstrated by overexpression of Tsg101 which rescues the release of the YPXnL mutants. Similarly,
overexpression of Alix not only enhances release of the PTAP mutant by a factor of four but also the release of a
triple mutant, indicating that additional cryptic YPXnL domains with a low affinity for Alix may be present. No
L-domain activity is provided by the proline-rich peptides at the Gag C-terminus.
Conclusions: Our data demonstrate that HERV-K(HML-2) release is predominantly mediated through a consensus
PTAP motif and two auxiliary YPXnL motifs in the p15 protein of the Gag precursor.
Keywords: HERV-K(HML-2), Gag protein, Late assembly domain, Budding, Retrovirus, Alix, Tsg101, Endogenous
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The Gag precursor plays an essential role in retroviral
assembly and release [1,2]. It contains domains that
mediate an association with the lipid bilayer, Gag-Gag
subunit-interactions and egress from the producer cell.
Successful budding ending with membrane scission to
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reproduction in any medium, provided the ormotifs of this protein termed ‘late (L)-domains’. Dele-
tions or explicit mutations in viral L-domains freeze the
budding step and prevent the separation of virions from
the plasma membrane [3,4].
To date, three characteristic classes of L-domains have
been defined, namely PT/SAP, YPXnL and PPXY. An
L-domain extends beyond the largely preserved core
amino acids. A functional PT/SAP class of L-domains
can be as large as 12 amino acids. L-domains function
by directly or indirectly linking the Gag precursor
proteins to the cellular ESCRT machinery principallyl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the biogenesis of multivesicular bodies. This machinery
consists of about 25 cellular proteins that form four
major complexes termed ESCRT-0, -I, -II and -III [5].
The three classes of L-domains found in viruses inter-
act with different sorting complex proteins to gain
access to the ESCRT pathway. The PT/SAP motif inter-
acts with Tsg101 (tumour susceptibility gene 101), an
ESCRT-I complex component, which was identified in
yeast two-hybrid experiments as an HIV-1 p6-interacting
protein. The depletion of Tsg101 by small interfering
RNA interrupts HIV-1 budding to a large extent [6]. On
the other hand, the PPXY motif functions through a
direct recruitment of Nedd4 (neuronal precursor cell-
expressed developmentally down-regulated-4)-like ubi-
quitin ligases by binding to its multiple WW domains
[7]. Ubiquitinylation is a critical step in processes involv-
ing the ESCRT pathway and viral budding [8-10]. Direct
ubiquitin fusion to Gag can functionally compensate for
the absence of a retroviral L-domain and the eventual
recruitment of an ubiquitin ligase to the budding particle
[10,11]. The third motif, YPXnL, associates with a pro-
tein named Alix (Apoptosis-linked gene 2-interacting
protein) [12,13]. The 97 kDa adaptor protein provides a
direct link between ESCRT-I and ESCRT-III complexes. It
interacts with ESCRT-III by means of its N-terminal Bro1
domain and with Tsg101 via its C-terminal proline rich re-
gion. A central region of the protein mediates binding to
the YPXnL motif present, for example, in the p9 protein of
equine infectious anaemia virus (EIAV) [12,13]. Therefore,
all three L-domain motifs appear to enter the same core
scission complex, albeit by different routes.
Several retroviruses contain more than one type of
L-domain motif, and these are often closely spaced or
even overlapping. For example, Mason Pfizer monkey
virus (MPMV), a close relative of HERV-K(HML-2), har-
bors a PSAP sequence four amino acids downstream of
a PPPY motif within its pp24/16 protein [14]. Further-
more, the human T-cell leukemia virus type I (HTLV-I)
contains a bipartite PPPYVEPTAP motif and HIV-1 has,
in addition to its primary PTAP motif, an additional
L-domain of the YPXnL type [13,15]. Beside the
L-domains, the nucleocapsid protein is also engaged in
the budding process through an interaction with the
Bro1 domain of Alix [16].
While the budding of exogenous retroviruses has been
well characterized, little is known about this process for
endogenous retroviruses, although a PTAP motif was re-
cently identified in the Gag of the human endogenous
retrovirus (HERV)-K(HML-2) [17-19]. HERVs are relicts
of infectious exogenous retroviruses whose proviruses
became integrated into the human genome millions or
at least hundred thousands of years ago [20,21]. They
comprise approximately 8% of human DNA and severalof these elements have been linked to oncogenesis,
neurological disorders and autoimmune diseases [22-25].
Despite the fact that all the known elements carry muta-
tions that prevent productive replication, functional pro-
teins and mature virus-like particles of the HERV-K
(HML-2) subfamily are expressed [26]. The study of
virus assembly and other aspects of these archaic retro-
viruses have been facilitated by the generation of con-
sensus sequences and reconstitution of original virus
sequences that allow expression of functional proteins
[17,27-29].
In this present report, we show that HERV-K(HML-2)
uses two distinct types of L-domain motifs to hijack the
ESCRT pathway. Mutation of a single nucleotide in the
PTAP motif of the HERV-K(HML-2) Gag p15 protein
leads to a characteristic L-domain phenotype, with
viruses arrested at a late stage of release. Our results in-
dicate that the PTAP motif is the core of the principal
L-domain of the virus. However, at least two auxiliary
YPXnL L-domains in p15 are present that efficiently pro-
vide alternative access to the ESCRT pathway, if the pri-
mary L-domain is restricted and Alix is overexpressed
allowing an assembly of the ESCRT-III complex.
Results
Generation and expression of a molecular clone of HERV-
K113 in which non-synonymous postinsertional mutations
are reverted
By alignment with ten other well-preserved human-
specific HERV-K(HML-2) elements, we recently identi-
fied putative non-synonymous postinsertional mutations
in the env, rec and gag-pro-pol open reading frames of
the HERV-K113 element described by Turner and co-
workers [30] and successfully expressed the reconsti-
tuted proteins [17,28]. To generate a molecular clone of
HERV-K113 expressing these reconstituted proteins
(termed oriHERV-K113), the entire sequence of the
element was cloned into the pBSK plasmid vector [31]
and site directed mutagenesis used to revert the previ-
ously reported 25 non-synonymous putative postinser-
tional mutations [17,24,28]. Three additional changes
(T8588C, A8799G and T9133C) were introduced in
the 3′LTR to match it with the 5′LTR sequence (see
Additional file 1). Silent mutations and presumed further
postinsertional mutations in non-coding regions were
not changed. Transfection of the pBSKoriHERV-K113
plasmid into HEK 293T cells resulted in the production
and release of virus like particles as demonstrated by re-
verse transcriptase activity in the supernatant (Figure 1A)
and thin-section electron microscopy of the producing
cells (Figure 1B). The released particles were not able to
establish a productive infection and replicate in HEK
293T, Tera-1, SK-Mel13 or other cell lines we have
tested so far (data not shown).
Figure 1 Expression of a HERV-K113 sequence with reverted non-synonymous postinsertional mutations. (A) Detection of RT activity in
the supernatants of HEK 293T cells transfected with the molecular clone of oriHERV-K113. (B) Thin section EM demonstrates production of mature
virions (left panel) that bud with C-type morphology (right panel).
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sor protein of the reconstituted HERV-K113 element
To identify potential late domains of HERV-K(HML-2)
the amino acid sequence of the oriHERV-K113 Gag
precursor was screened for motifs that match or at least










Figure 2 Schematic representation of a HERV-K(HML-2) provirus and
Genomic structure of the provirus. The Gag protein encodes the matrix pro
and two small peptides (QP1 and QP2). A PTAP and two YPXnL motifs with
sequence resembling a PPPY L-domain is present in QP2. The position of t
is given.During this search and evaluation we took into account
the fact that retroviral late domains are frequently found
in Gag regions encoding phosphoproteins located be-
tween the matrix and capsid (as for example in MPMV)
and in short proteins adjacent to the nucleocapsid (as in






the position of presumed L-domains within the Gag protein.
tein (MA), a spacer peptide (SP1), p15, capsid (CA), nucleocapsid (NC)
presumed L-domain function are present in the p15 protein. A PPPQ
he first amino acid of each motif in the Gag protein of oriHERV-K113
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of p15 together with two potential YPXnL motifs, of
which one is situated just 10 amino acids further
towards the N-terminal (Figure 2). In addition, the
proline-rich QP1 and QP2 peptides at the C-terminus of
the Gag precursor contain PPPQ motifs that resemble
the canonical PPPY sequence of L-domains directly
interacting with Nedd4-like ubiquitin ligases [7,17].Figure 3 Deletion of the QP1 and QP2 peptides do not affect HERV-K
supernatants of cells expressing the wild type oriHERV-K113 and the QP1/2
tion of a luciferase expression plasmid. Data represent means of four samp
activity with the wild type virus was set at 100%. (B) Released viral particles
Western blot was probed with a CA-specific polyclonal serum or an actin s
mutant morphology. Electron micrographs show mature particles released
were detectable.The proline-rich peptides QP1 and QP2 do not harbor late
domain activity
We first examined whether the 23-amino-acid-long QP1
and the 19-amino-acid-long QP2 peptides that contain a
PPPQ motif play a role in HERV-K(HML-2) budding
and release. The first codon of QP1 was substituted for
a stop codon to terminate the Gag precursor at this site
and prevent expression of both peptides. HEK 293T cells(HML-2) release. (A) Reverse transcriptase (RT) activity in the
deletion mutant (ΔQP). The RT activity was normalized by cotransfec-
les with error bars (standard error) of a representative experiment. The
were pelleted by ultracentrifugation and subjected to SDS-PAGE. The
pecific antibody. (C) Electron microscopic analysis of the WT and ΔQP
from HEK 293T cells. No differences in the morphology of the particles
Chudak et al. Retrovirology 2013, 10:140 Page 5 of 14
http://www.retrovirology.com/content/10/1/140were then transfected with the wild type plasmid
expressing oriHERV-K113 and the QP1/2 deletion
mutant (ΔQP) along with a luciferase vector to
normalize for transfection efficiency. Comparable
levels of RT activity (Figure 3A) and p27 capsidFigure 4 Mutation of the PTAP motif impairs particle release and ind
release of viral particles in HEK 293T cells. Data represent the mean of four
(left panel) and lysates of the producer cells (right panel). The Gag precurso
and detected by Western blotting. The lysate of the PTAP mutant contains
presumably reminiscent of released mature viruses attached to the cells. (C
mutant oriHERV-K113.protein (Figure 3B) were measured in the superna-
tants of the wild type and mutant. Furthermore, no
evidence for a late domain phenotype was evident in
thin section electron microscopy (Figure 3C). These
findings indicate that the two C-terminal polypeptidesuces an L-domain phenotype. (A) Effect of PTAP inactivation on the
experiments with standard errors. (B) SDS PAGE of pelleted virions
r and processed CA proteins in cell lysates were immunoprecipitated
more p74Gag precursor protein and less p27 CA. The p27 CA protein is
) Thin section EM analysis of HEK 293T cells transfected with PTAP
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domain functions to the virus.
The PTAP motif in p15 is the core of a bona fide late
domain
Of all potential L-domains in the HERV-K(HML-2) Gag
protein, the PTAP motif at position 253 is considered to
be most likely a late domain because of its location and
perfect match to the consensus sequence. To determine
the effect of its inactivation, the threonine at position
254 was substituted with alanine (T254A) in oriHERV-
K113 and the mutant designated as PTAP-. Supernatants
from HEK 293T cells transfected with the PTAP mutant
showed a 6-fold decrease in RT activity compared to
wild type (Figure 4A). The reduced release of the PTAP
mutant was also seen in the intensity of the p27 CA pro-
tein band in Western blots of the virus pellet (Figure 4B
left panel). The Western blot analysis of the cell lysate
reveals somewhat more immature Pr74Gag precursor
and slightly less p27 CA compared to the wild type virus
(Figure 4B right panel), which is in accordance with a
reduced ratio of released viruses. Thin section electron
microscopy of the PTAP mutant was used to visualise
the potential late domain phenotype. Indeed, in contrast
to the wild type (Figures 1 and 3), the PTAP mutant
showed predominantly immature virus particles arrested
at a late budding stage at the cell membrane (Figure 4C
left panel). Furthermore, high numbers of aberrant bud-
ding structures were detected, mainly in the form of
chain buds in which different procapsids are connected
by membrane stalks (Figure 4C right panel).
Tsg101 is recruited to the PTAP motif in the Gag p15
protein
Tsg101 is an essential component of the ESCRT-I com-
plex and has been shown to interact directly with the
PTAP motifs of several retroviruses [6,33,34]. We there-
fore investigated the subcellular colocalization of HERV-
K(HML-2) Gag and Tsg101 to provide further evidence
for a conventional role of this virus’s p15 protein PTAP
motif. A codon-optimized version of the oriHERV-K113
gag sequence [17] was cloned in-frame upstream of the
Cherry fluorescent protein and a PTAP mutant gener-
ated by substituting the threonine for alanine.
Expression of both the wild type and PTAP mutant
Gag-Cherry fusion proteins resulted in an accumulation
of the proteins at presumed budding sites at the cell
membrane (Figure 5). Coexpression of an HA-tagged
Tsg101 protein revealed significant colocalization of the
wild type Gag-Cherry with HA-Tsg101 (Figure 5B).
Without Gag-Cherry coexpression, HA-Tsg101 expres-
sion was diffusely cytoplasmic with dot-like staining
(Figure 5A), which is consistent with previous observa-
tions [35]. This indicates that Tsg101 is recruited to theGag clusters at the cell membrane and this appears to
depend on a functional PTAP motif because it was
not evident during expression of the PTAP mutant
(Figure 5C). Moreover, a mutant Tsg101 variant, Tsg-3′,
with a deletion of the N-terminal UEV (Ubiquitin E2
variant) domain responsible for the interaction with
HIV-1 p6 PTAP motif [34,36], did not colocalize with
the wild type Gag-Cherry protein (Figure 5D). Tsg-3′
localization differs from full-length Tsg101 by the forma-
tion of large vacuolar structures that are not colocalized
with Gag-Cherry. These results strongly suggest that the
PTAP motif in the p15 protein provides the link to the
ESCRT-I complex by binding to the Tsg101 protein.
The two YPXnL motifs in the Gag p15 protein serve as
supplementary late domains
In addition to the PTAP motif, the HERV-K(HML-2)
p15 protein contains two putative, uncharacterized
L-domains of the YPXnL type (Figure 2). To evaluate the
functionality of each with regard to virus release,
mutations previously shown to inactivate this type of
L-domain [11,37] were introduced. In addition, double
mutants with inactivated PTAP motifs and a triple mu-
tant with inactivation of both YPXnL motifs and the
PTAP motif were prepared (Table 1).
HEK 293T cells were then transfected with the mu-
tants and the wild type oriHERV-K113. As shown in
Figure 6A, inactivation of the N-terminal YPXnL motif
(YPXnL1) resulted in a 40% reduction in virus release
whereas mutation of the YPXnL motif (YPXnL2) adjacent
to PTAP led to a 64% decrease in supernatant RT activ-
ity. Furthermore, the impact of the double YPXnL muta-
tions was significantly higher, reducing release by about
95%. Mutations of each of the single motifs resulted in a
modest additional drop in the release of the PTAP mu-
tant whereas the triple mutation reduced release to
background levels (Figure 6A). These results were con-
firmed by Western blotting of virus pellets in which the
synergistic effect of the YPXnL double mutant is clearly
visible (Figure 6B). Moreover, using thin section electron
microscopy, the typical phenotype of L-domain mutants
was frequently seen in cells transfected with the YPXnL
mutants (Figure 6C).
Inhibition of Tsg 101 or Alix expression by RNA
interference significantly reduces HERV-K(HML-2) release
In order to corroborate an involvement of Tsg101
and Alix in the release process of HERV-K(HML-2)
virions we have transfected HEK 293T cells with the
pBSKoriHERV-K113 plasmid along with a mix of two
siRNAs previously shown to efficiently down regulate
Tsg101 or with another mix of two siRNAs targeting the
Alix mRNA [6,38-40]. As expected, a significant down
regulation of Tsg101 and Alix has been achieved by the
Figure 5 Tsg101 is recruited by the PTAP motif of HERV-K(HML-2) Gag to sites of particle egress. Cells were visualized by confocal
microscopy as described in the material and methods. Scale bar is 20 μm. (A) HEK 293T cells were transfected either with a full-length HA-Tsg101
expression vector or with Gag-Cherry alone. (B) Colocalization of HA-Tsg101 and Gag-Cherry in cells expressing both proteins. (C) No colocaliza-
tion is observable if GagPTAP--Cherry is expressed. (D) HA-Tsg-3′, a mutant lacking the UEV domain, also fails to colocalize with Gag-Cherry.
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control (Figure 7A). The inhibition of Tsg101 expression
as well as the inhibition of Alix expression had both a
strong effect on virus release monitored 48 hours post
transfection by Western blot (Figure 7B). These results are
in line with our previous findings pointing towards a
major role of Tsg101 and Alix in the budding and release
process of the investigated endogenous betaretrovirus.Overexpression of Tsg101 rescues budding of the HERV-K
(HML-2) YPXnL mutants and Alix overexpression rescues
release of PTAP mutants
Since full-length Tsg101 only colocalized with an intact
HERV-K(HML-2) Gag PTAP domain, it was important
to know whether overexpression of the protein could
rescue the budding and release rates of YPXnL mutants.
We therefore cotransfected HEK 293T cells with
Table 1 Overview of the p15 L-domain mutants used in
the study

















Chudak et al. Retrovirology 2013, 10:140 Page 8 of 14
http://www.retrovirology.com/content/10/1/140plasmids encoding HA-Tsg101 and with plasmids encod-
ing either oriHERV-K113 or the various L-domain
mutants. The efficiency of egress was determined by
measuring RT activity in the supernatants at 48 h post
transfection. Overexpression of Tsg101 was found to
slightly reduce the release of wild type virus (Figure 8),
as reported previously and attributed to intracellular
perturbations of the endosomal compartment by overex-
pression of the protein [41]. In the presence of a func-
tional PTAP motif, overexpression of Tsg101 resulted in
a significant increase in the release of the YPXnL single
and double mutants. As expected, this increase was not
seen with mutants carrying a mutation in the PTAP
motif. These data indicate that overexpression of Tsg101
can largely compensate for a lack of a functional YPXnL
type L-domain and confirm the contribution of Tsg101
to the budding of HERV-K(HML-2). The data also indi-
cate that the PTAP motif in p15 is the only site in the
viral proteins that enables interaction with Tsg101. The
expression of HA-Tsg101 and FLAG-Alix was confirmed
by immunofluorescence (data not shown).
Analogous to the rescue of HERV-K(HML-2) YPXnL
defects by ectopic Tsg101 expression described above,
previous studies have documented that overexpression
of Alix can rescue budding defects of HIV-1 PTAP
L-domain mutants [12,42]. We therefore used our
HERV-K(HML-2) PTAP mutants to determine whether
overexpression of Alix also increases their release.
Cotransfection of FLAG-Alix plasmids indeed partially
abrogated the PTAP defects in mutants with one or two
wild type YPXnL motifs. Surprisingly, release of even the
virus with mutations in both YPXnL motifs was rescued,
reaching levels of up to 50% of the wild type (Figure 8).
As well as being in line with the identified functional
YPXnL motifs, these findings also potentially indicate
the presence of at least one additional, unidentified cryp-
tic YPXnL motif. Alternatively, low expression and in-
corporation of chromosomally encoded Gag proteins
into nascent viral particles might also explain the rescue
by high cytoplasmic levels of Alix. Indeed, we previouslydemonstrated very low levels of HERV-K(HML-2) tran-
scripts in HEK 293T cells by sensitive RT-PCR [31].
Effect of L-domain mutants in Tera-1 cells expressing high
levels of chromosomally encoded HERV-K(HML-2)
To further test the hypothesis that incorporation of
chromosomally encoded HERV-K(HML-2) Gag-proteins
can rescue ectopically expressed HERV-K(HML-2) mu-
tants, Tera-1 cells were transfected with plasmids encod-
ing wild type and mutants of oriHERV-K113. Tera-1
cells are known to express HERV-K(HML-2) Gag pro-
teins, including those with preserved L-domains [43].
Indeed, especially the release of the PTAP mutant was
significantly less impaired compared to HEK 293T cells.
In contrast to the virtually complete block in HEK 293T
cells, the triple mutant showed only an 80% reduction in
particle release (Figure 9). These results support the pos-
sibility that chromosomally encoded Gag proteins are in-
corporated into nascent particles, rescuing release of
ectopically expressed L-domain mutants.
Discussion
The human genome encodes about 90–100 well-
preserved proviruses of the HERV-K(HML-2) family
[44]. Several of these proviruses code for Gag proteins
that can form retroviral particles upon expression. Using
electron microscopy and other methods, we and others
have demonstrated that these particles bud in a C-type
manner and are in principle able to ‘pinch off ’ from the
cell membrane and undergo maturation [17,27,45]. To
identify the protein motifs of HERV-K(HML-2) that
govern the release of these ancient retroviruses,
we generated a reconstituted HERV-K113 element in
which non-synonymous postinsertional mutations were
reverted (termed oriHERV-K113). The lack of such
mutations renders consensus sequences or reconstituted
sequences of endogenous retroviruses and retroelements
suitable for general functional analyses of their proteins
[17,27-29,46].
Guided by knowledge of the common position and
consensus sequences of late domains in exogenous ret-
roviruses, we performed an in silico screen of the
oriHERV-K113 sequence and identified a potential
PTAP motif and two YPXnL motifs in the p15 protein
localized between the matrix and capsid subunits of
Gag. One of the YPXnL domains, a YPETL sequence, is
found N-terminal in the p15 protein. The second, a
YPQPPTRRL sequence, is located just 10 amino acids
upstream of the PTAP motif with only a single interven-
ing amino acid. Closely spaced L-domains are very
frequently observed in retroviruses and some other
enveloped viruses [47,48]. In the lentivirus HIV for ex-
ample, a PTAP and a YPXnL L-domain is located in the
phosphoprotein p6 at the C-terminus of the Pr55Gag [3].
Figure 6 The YPXnL1 and the YPXnL2 motifs function as additional L-domains. (A) Comparison of the release of various L-domain mutants
from transfected HEK 293T cells with that of the wild type oriHERV-K113. Means and standard errors of a representative experiment performed in
quadruplicates are shown. (B) SDS-PAGE of virus pellets from the supernatants of HEK 293T cells transfected with WT and L-domain mutants. The
Western blots were probed with a rat-anti-p27 CA serum. The cell lysates were in addition hybridized with an anti-actin antibody. A representative
experiment of four performed is shown. The star depicts an unspecific band. (C) EM analysis of YPXnL defective phenotypes in HEK 293T cells.
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Figure 7 Inhibition of Tsg101 and Alix expression by RNA
interference effects HERV-K(HML-2) egress. (A) A significant
down regulation of Tsg101 (left panel) and Alix (right panel) was
achieved in HEK 293T cells with siRNAs specific for the respective
mRNAs. (B) For the determination of the impact of Tsg101 or Alix
inhibition of HERV-K113 release, pBSK-oriHERV-K133 was contra-
nsfected with specific siRNAs or non-target siRNAs as control.
Twenty-four hours post transfection the virus from the supernatants
and the cell lysates were loaded on a Western blot. The blot was
probed with a rat anti-p27 serum.
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rich peptides at the C-terminus with unknown functions
[17]. Although a conventional L-domain motif is not
evident in these peptides, sequences closely resembling a
PPPY motif are present, making this a region of interest.
Deletion mutants unable to express these peptides
showed no impairment or defect in particle release,
strongly arguing against them having an L-domain
function.
In contrast to this C-terminal deletion mutant, a
T254A substitution in the PTAP sequence (known to in-
activate this L-domain) reduced particle release in HEK
293T cells by a factor of approximately six, and thin sec-
tion EM revealed a classical late domain phenotype withan abundance of particles at the membrane unable to
finalize the last steps of release and ‘pinch off ’. A similar
defect in particle release in a PTAP mutant of the
HERV-K(HML-2) consensus sequence has also been re-
cently reported [18]. The function of this sequence as
core of an L-domain has been further substantiated by
colocalization studies of the HERV-K(HML-2) Gag with
the ESCRT-I complex protein Tsg101. While full length
Tsg101 is found in association with Gag at presumed
budding sites, this is not the case if the PTAP mutant is
expressed, indicating that the PTAP motif at position
253 is the only Tsg101 binding site for this virus’s Gag
protein. This is supported by the fact that overexpres-
sion of Tsg101 fails to increase the release of the PTAP
mutant. Consistent with previously published observa-
tions with HIV and other viruses, overexpression of
Tsg101 resulted in a moderate decrease of wild type re-
lease that can be explained by a partial disorder of cellu-
lar endosomal sorting pathways [41,49]. On the other
hand, transfection of HEK 293T cells with a Tsg101 ex-
pression plasmid increased significantly the release of
both YPXnL L-domain mutants and of the version carry-
ing mutations in both YPXnL motifs. Inactivation of each
of the presumed two YPXnL L-domains reduced particle
release and induced a late phenotype, although less dra-
matically than did mutation of the PTAP motif. By thin
section EM we observed changes in quantity but no
morphologic differences in the PTAP and the YPXnL
mutants.
The impact of the mutations regarding the degree of
virus release indicates that in HEK 293T cells the PTAP
motif is the dominant L-domain and each of the YPXnL
motifs play a supportive role. We obtained similar re-
sults with SK-Mel13 cells, with a more pronounced in-
hibition (up to 95%) of release by the PTAP mutant
(data not shown). However, in other cell types the PTAP
motif might be of less relevance if, for example, more
Alix and less Tsg101 is expressed. The relevance of dif-
ferent types of L-domains is known to be cell type
dependent [50]. For efficient budding retroviruses must
recruit the ESCRT-III complex. It provides the mechan-
ical means for scission of the virus from the cell mem-
brane. This complex can be recruited via the ESCRT-I
or ESCRT-II route, though Alix appears to be used in
both pathways. Alix interacts with the ESCRT-III com-
plex so that by high Alix levels or overexpression of this
protein the downstream ESCRT-III complex is assem-
bled and budding can be restored. However, the process
is much more efficient if the ESCRT-I complex is avail-
able [51].
In HEK 293T cells, mutation of both YPXnL L-
domains has a synergistic effect on particle release com-
pared with that of individual motif mutants, resulting in
a stronger inhibition than that seen with the PTAP
Figure 8 Overexpression of Tsg101 and Alix rescue HERV-K(HML-2) defective L-domain mutants. HEK 293T cells were transfected with WT
or oriHERV-K113 L-domain mutants with and without cotransfection of HA-Tsg101 or FLAG-Alix. A luciferase vector was added for normalization.
RT activities in the supernatants were determined at 48 h post transfection and normalized. The adjusted RT activities are shown in relation to the
WT. The means of three experiments performed in quadruplicate are shown with standard error bars. The quantity of DNA per transfection was
held constant by addition of an empty pcDNA3.1 vector.
Figure 9 Release of HERV-K(HML-2) L-domain mutants in Tera-1
cells. Tera-1 cells expressing considerable amounts of HERV-K(HML-2)
Gag were transfected with oriHERV-K113 or with the L-domain mutants
indicated. RT activity in the supernatants was detected 48 h post trans-
fection and the data represent means and standard errors of an experi-
ment performed in quadruplicate. The activity obtained with the wild
type was set at 100%.
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particle release following siRNA mediated down regula-
tion of Alix or Tsg101 expression. The close proximity
of the PTAP motif to one of the YPXnL L-domains sug-
gests that mutation in one of these domains might also
inactivate the other. This, however, appears not to be the
case as variants carrying mutations in both motifs
(YPXnL2 + PTAP) are more impaired than the single
motif mutants. Moreover, overexpression of Tsg101 is
able to partially rescue the release of the variant carrying
an inactivating mutation in the nearby YPXnL motif,
demonstrating the presence of a functional PTAP motif.
In turn, Alix overexpression can partially rescue a virus
that carries inactive PTAP and N-terminal YPXnL1 mo-
tifs, providing further evidence that YPXnL motifs func-
tion as L-domains in HERV-K(HML-2) Gag. However,
the triple mutant carrying inactivating mutations in both
YPXnL L-domains plus the PTAP domain is still partially
rescued by Alix overexpression. Therefore, there may be
one or more additional cryptic sites with low affinity for
Alix that allow interaction with this protein (if overex-
pressed) and provide access to the ESCRT machinery. Al-
ternatively, low-level expression of Gag from proviruses
encoded in the chromosomes of HEK 293T cells might,
under such circumstances, be sufficient to allow release of
this mutant. Although HEK 293T cells express HERV-K
(HML-2) transcripts at barely detectable levels [31], incorp-
oration of Gag from endogenous proviruses with functional
L-domains is very likely since even HIV Pr55Gag has been
shown to be integrated into nascent HERV-K(HML-2) par-
ticles [18]. Even a minor fraction of Gag proteins with func-
tional L-domains per particle is sufficient to confer egress
from the cell [14] and our results with Tera-1 cells that ex-
press considerably higher levels of endogenous Gag supportthis hypothesis. The expression of a minority of Gag pro-
teins with functional L-domains might be the reason why
many tumor cells are able to release HERV-K(HML-2) par-
ticles. The particle production of the PTAP and triple mu-
tants in Tera-1 was only moderately impaired, with a 5-fold
reduction in the release of the triple mutant compared to
complete inhibition in HEK 293T cells. However, further
experiments are needed to confirm or refute the presence
of cryptic Alix binding sites in the HERV-K(HML-2) Gag
protein and to analyze the effects of incorporation of low
fractions of Gag proteins with functional L-domains.
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This study identifies three L-domains in a partially
reconstituted prototypical HERV-K(HML-2) virus. The
major L-domain, providing access to the ESCRT com-
plex via the Tsg101 protein, is a consensus PTAP motif
in the C-terminus of the p15 protein. Based on muta-
genesis studies and rescue experiments with Alix overex-
pression, this L-domain was shown to be supported by
two auxiliary YPXnL motifs also located in the p15 pro-
tein of the virus. By providing essential information
concerning the relevant functional domains facilitating
HERV-K(HML-2) particle release, these results advance
our understanding of the biology of these ancient and
inherited elements preserved within our genomes.
Methods
Cell culture
HEK 293T, SK-Mel13 and Tera-1 cells were cultured in
complete Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum, L-glutamine
(2 mM), penicillin (50 U/ml) and streptomycin (50 μg/ml).
Plasmid DNA construction
For the generation of the pBSKoriHERV-K113, the pro-
viral sequence of HERV-K113 (GenBank AY037928) was
amplified from the RP11-12X BAC-library plasmid [30]
and cloned into the small pBlueskript SK+ (pBSK) vector
from Stratagene using Apa I and Not I as restriction sites.
The identification of the presumed 25 non-synonymous
postinsertional mutations has been described elsewhere
[17,24,28]. These mutations and the three mutations in
the 3′LTR (see Additional file 1) were introduced into
pBSK-HERV-K113 by site-directed mutagenesis using the
QuikChangeW Multi Site-Directed Mutagenesis Kit from
Agilent Technologies to produce pBSKoriHERV-K113.
The L-domain mutants were also generated by
site-directed mutagenesis using the same Kit and the





gagctaatcctacggcaccac-3′. The primer 5′-caacaaactggg
gcattctgaattcagccatttgttcc-3′ was used for the introduc-
tion of the stop codon after NC to generate the ΔQP-
mutant and the primer 5′-cctcccaccaggcggctgaacgccc
ctcccagcaggcagagcgag-3′ to introduce the PTAP--muta-
tion into the codon-optimized Gag in the pGag-Cherry
vector. The reverse complement oligonucleotides primers
used in the mutagenesis reactions are not shown.
The pGag-Cherry construct was designed for immuno-
fluorescence microscopy in which the synthetic partially
codon-optimized gag sequence (described previously)
was cloned using the Sac I and Kpn I sites of apmCherry-N1 vector [17,28]. The PTAP mutant pGagP-
TAP--Cherry was generated as described above using
the QuikChange® Multi Site-Directed Mutagenesis Kit
(Agilent Technologies). pcGNM2/Tsg-F and pcGNM2/
Tsg-3′, used to express Tsg101 and Tsg-3′, respectively,
were kind gifts of Eric Freed (University of Maryland,
USA). The plasmid pCMV-FLAG-ALIX was kindly
provided by Jörg Votteler (University of Erlangen,
Germany). The small interfering RNAs (siRNA) used to
down regulate Tsg101 has been previously described
[6,38] as well as the Alix specific siRNAs [39,40]. As
non-target siRNA the “AllStars Neg. Control siRNA”
(Qiagen) was used.
RT activity and luciferase assays
HEK 293T cells (6 × 105) were seeded into 6-well
plates and transfected the following day with 1.95 μg
pBSKoriHERV-K113 or mutant constructs using Polyfect
(Qiagen) according to the manufacturer’s instructions. In
addition, 0.05 μg pGL3-Promotor Vector (Promega) was
included for normalization. Samples of cell culture media
taken 48 h after transfection were filtered (0.45 μm) and
RT activity measured using the HS-Mg RT Activity Kit
(Cavidi, Uppsala, Sweden). Luciferase activity in trans-
fected cells lysed 48 h post transfection (using the
Luciferase Cell Culture Lysis 5x Reagent from Promega)
was measured using the Promega Luciferase Assay Kit.
Virus particle purification and preparation of cell lysates
2.4 × 106 HEK 293T cells grown in 100 mm dishes were
transfected with the different plasmids (25 μg each)
using calcium phosphate. At four days post transfection,
samples of culture media were harvested, clarified at
3345 × g for 8 min and filtered (0.45 μm) to remove cell
debris. The supernatants were then centrifuged at
175,000 × g for 3 h at 4°C through a 20% sucrose cush-
ion in a Beckman SW32Ti rotor. Virus pellets were
resuspended in 60 μl 0.05 M Hepes buffer, pH 7.2 for
Western blot analysis. To prepare cell lysates, trans-
fected cells were resuspended in cell lysis buffer
(1% Triton-X 100, 20 mM Tris pH 7.7, 150 mM NaCl)
containing complete protease inhibitor cocktail (Roche
Diagnostic). For the Tsg101 and Alix depletion assays, 4
μg of pBSKoriHERV-K113 were cotransfected with a
mix of 6 μl of two specific siRNAs (20 μM) or the same
amount (12 μl, 20 μM) of control siRNA using Attrac-
tene (Qiagen) according to the transfection protocol.
The transfections were performed in 6-well plates in
triplicates. For Western blot analyses the supernatants
and the cell lysates of the triplicates were combined.
SDS PAGE and western blot analysis
Viral lysates or pelleted virus particles were mixed with
sample buffer and boiled for 10 min before being
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electrophoresis (SDS-PAGE). The proteins were trans-
ferred onto a PVDF membrane (Roth) and after blocking
in blocking buffer (phosphate-buffered saline-PBS, 5%
skim milk powder, 0.1% Tween), the membranes were
probed with anti-CA rat sera as described previously
[17] and a secondary horseradish peroxidase-conjugated
goat-anti-rat antibody (Sigma-Aldrich). For the detection
of Tsg101 the mouse monoclonal antibody 4A10 (Gene-
tex) was used and for the detection of Alix a goat poly-
clonal IgG (Q-19; Santa Cruz Biotech) was applied as
primary antibody with species specific secondary anti-
bodies in both cases. The β-actin was detected with the
AC-74 monoclonal antibody (Sigma-Aldrich). Proteins
were visualized using Super Signal West Femto Max-
imum Sensitivity Substrate (Thermo Scientific) and a
Kodak Medical X-ray film.
Immunofluorescence microscopy
HEK 293T cells were cultured in chamber slides (Nunc)
and transfected using Polyfect (Qiagen). Twenty-four
hours post transfection, cells were fixed at room
temperature with 2% paraformaldehyde in PBS for
30 min. Cells were then rinsed three times with PBS and
permeabilized with 0.5% Triton-X100. After blocking
with 1% skim milk powder in PBS for 30 min, cells were
incubated with primary mouse anti-HA antibody diluted
1:200 in blocking buffer for 1 h at 37°C. Cells were then
washed three times with PBS and incubated with a sec-
ondary Alexa-488 conjugated anti-mouse-IgG antibody
(Invitrogen) for 1 h. After repeated washings, cell nuclei
were stained using DAPI (4′,6-diamidino-2-phenylin-
dole) at 0.2 ng/ml. Finally, the cells were mounted in
Mowiol and examined using a Zeiss LSM 780 confocal
laser scanning microscope.
Electron microscopy
Transfected HEK 293T cells were fixed using 2.5% glu-
taraldehyde in 0.05 M Hepes (pH 7.2) for 1 h at room
temperature. The methods for embedding and for the
preparation of thin section transmission EM images have
been described elsewhere [17].
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